Equities Analysts Offer Predictions for Biogen Q1 Earnings
Biogen Inc. (NASDAQ:BIIB – Free Report) – Equities research analysts at Zacks Research reduced their Q1 2026 earnings per share (EPS) estimates for shares of Biogen in a report issued on Wednesday, March 12th. Zacks Research analyst S. Ganoria now forecasts that the biotechnology company will earn $3.49 per share for the quarter, down from […]
